AVNS logo

Avanos Medical, Inc. Stock Price

NYSE:AVNS Community·US$547.1m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 1 Fair Values set on narratives written by author

AVNS Share Price Performance

US$11.79
-10.79 (-47.79%)
US$11.79
-10.79 (-47.79%)
Price US$11.79

AVNS Community Narratives

There are no narratives available yet.

Recent AVNS News & Updates

Avanos Medical: After Transformation Efforts, I Expect Inorganic Growth To Push The Price Up

Oct 05

Avanos Medical, Inc.'s (NYSE:AVNS) Revenues Are Not Doing Enough For Some Investors

Aug 06
Avanos Medical, Inc.'s (NYSE:AVNS) Revenues Are Not Doing Enough For Some Investors

Avanos Medical, Inc. Key Details

US$692.5m

Revenue

US$319.7m

Cost of Revenue

US$372.8m

Gross Profit

US$834.1m

Other Expenses

-US$461.3m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
Earnings per share (EPS)
-9.94
Gross Margin
53.83%
Net Profit Margin
-66.61%
Debt/Equity Ratio
13.5%

Avanos Medical, Inc. Competitors

 
 
 
 
 
 
 
 
 
 
 
 

Snowflake Analysis

Flawless balance sheet and undervalued.

1 Risk
2 Rewards

About AVNS

Founded
2014
Employees
2227
CEO
David Pacitti
WebsiteView website
avanos.com

Avanos Medical, Inc., a medical technology company, provides medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides non-opioid pain solutions, including surgical pain and recovery products, which comprise ON-Q and ambIT surgical pain pump, Game Ready cold, and compression therapy systems. In addition, it offers interventional pain solutions, which provide minimally invasive pain-relieving therapies, such as COOLIEF chronic pain products; OrthogenRx knee osteoarthritis hyaluronic acid pain relief injection products; and Trident radiofrequency ablation products to treat chronic pain conditions. The company markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.

Market Insight

Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading

U.S. Market Performance

  • 7 Days: 0.9%
  • 3 Months: 8.7%
  • 1 Year: 18.4%
  • Year to Date: 14.8%
The market is up 1.2% over the last week, with the Information Technology sector leading the way, up 2.4%. As for the past 12 months, the market is up 18%. Looking forward, earnings are forecast to grow by 15% annually. Market details ›